A phase (ph) II, multi-center study of the safety and efficacy of tebentafusp (tebe) (IMCgp100) in patients (pts) with metastatic uveal melanoma (mUM) Meeting Abstract
| Authors: | Sacco, J. J.; Carvajal, R.; Butler, M. O.; Shoushtari, A. N.; Hassel, J. C.; Ikeguchi, A.; Hernandez-Aya, L.; Nathan, P.; Hamid, O.; Piulats Rodriguez, J. M.; Rioth, M.; Johnson, D. B.; Luke, J. J.; Espinosa, E.; Leyvraz, S.; Goodall, H. M.; Holland, C.; Abdullah, S.; Sato, T. |
| Abstract Title: | A phase (ph) II, multi-center study of the safety and efficacy of tebentafusp (tebe) (IMCgp100) in patients (pts) with metastatic uveal melanoma (mUM) |
| Meeting Title: | ESMO Immuno-Oncology Virtual Congress 2020 |
| Journal Title: | Annals of Oncology |
| Volume: | 31 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2020 Dec 9-12 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2020-12-01 |
| Start Page: | S1442 |
| End Page: | S1443 |
| Language: | English |
| ACCESSION: | WOS:000600992500065 |
| DOI: | 10.1016/j.annonc.2020.10.552 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 64MO -- Source: Wos |
